Anillin, Actin Binding Protein (ANLN) (N-Term) Peptid
Kurzübersicht für Anillin, Actin Binding Protein (ANLN) (N-Term) Peptid (ABIN8094623)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- ANLN Peptide - N-terminal region
-
Sequenz
- EHGKGSLEEA EAERLLLIAT GKRTLLIDEL NKLKNEGPQR KNKASPQSEF
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- ANLN Antibody (ARP79372_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Anillin (ANLN) (Anillin, Actin Binding Protein (ANLN))
-
Hintergrund
-
Background Information: This gene encodes an actin-binding protein that plays a role in cell growth and migration, and in cytokinesis. The encoded protein is thought to regulate actin cytoskeletal dynamics in podocytes, components of the glomerulus. Mutations in this gene are associated with focal segmental glomerulosclerosis 8. Alternative splicing results in multiple transcript variants encoding different isoforms.
Alternative Symbols: scra, FSGS8, Scraps
-
Molekulargewicht
- 123 kDa
-
Gen-ID
- 54443
-
NCBI Accession
- NP_001271230
-
UniProt
- Q9NQW6
Target
-
